Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
Our reframing acknowledges the nuanced reality of obesity and allows for personalized care,” said Dr. Francesco Rubino of ...
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
Obesity, which affects 650 million people worldwide, influences the development of cardiometabolic diseases and increases ...
The savings from the new list prices for those drugs were expected to generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees.